DBV Technologies (DBVT) Other Non-Current Liabilities (2015 - 2025)

DBV Technologies (DBVT) posted quarterly Other Non-Current Liabilities of $8.4 million for Q3 2025, up 8.52% year-on-year from $7.8 million in Q3 2024, and up 12.38% on a QoQ basis from $7.5 million in Q2 2025.

DBV Technologies (DBVT) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends

DBV Technologies (DBVT) has reported Other Non-Current Liabilities for 11 consecutive years, with $8.4 million the latest figure, recorded in Q3 2025.

  • Quarterly Other Non-Current Liabilities rose 8.52% year-over-year to $8.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $8.4 million (up 8.52% YoY) and the FY2024 annual result came in at $8.3 million, down 6.78% from the prior year.
  • Other Non-Current Liabilities rose to $8.4 million in Q3 2025 per DBVT's latest filing, from $7.5 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for DBVT reached as high as $17.0 million in Q3 2021 and fell as low as $1.3 million in Q1 2021.
  • A 5-year average of $8.1 million and a median of $8.3 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2021 — Other Non-Current Liabilities jumped 1706.46% — and 2024, when it sank 55.0%.
  • Year by year, Other Non-Current Liabilities stood at $2.1 million in 2021, then soared by 120.54% to $4.7 million in 2022, then soared by 88.68% to $8.9 million in 2023, then fell by 6.78% to $8.3 million in 2024, then grew by 1.45% to $8.4 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $8.4 million, $7.5 million, and $5.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 DBV Technologies 267.50 Mn 92.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 8.45 Mn
Jun 30, 2025 7.52 Mn
Mar 31, 2025 5.45 Mn
Dec 31, 2024 8.33 Mn
Sep 30, 2024 7.79 Mn
Jun 30, 2024 6.16 Mn
Mar 31, 2024 5.02 Mn
Dec 31, 2023 8.93 Mn
Sep 30, 2023 11.37 Mn
Jun 30, 2023 11.25 Mn
Mar 31, 2023 11.16 Mn
Dec 31, 2022 4.74 Mn
Sep 30, 2022 9.59 Mn
Jun 30, 2022 10.54 Mn
Mar 31, 2022 1.46 Mn
Dec 31, 2021 2.15 Mn
Sep 30, 2021 16.95 Mn
Jun 30, 2021 16.14 Mn
Mar 31, 2021 1.29 Mn
Dec 31, 2020 475,000.00